SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049091
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:42
Documents
6
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A copy_igm_def14a_fy2023_n.htm DEF 14A 1303853
2 GRAPHIC img179414989_0.jpg GRAPHIC 128304
3 GRAPHIC img179414989_1.jpg GRAPHIC 141645
4 GRAPHIC img179414989_2.jpg GRAPHIC 102300
5 GRAPHIC img179414989_3.jpg GRAPHIC 514842
6 GRAPHIC img179414989_4.jpg GRAPHIC 214112
  Complete submission text file 0000950170-24-049091.txt   2810398
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39045 | Film No.: 24883566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)